Dr. Dipali Trivedi, MD

Dr. Trivedi practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Trivedi's NPI, 1407055973, was assigned on July 16, 2007. Dr. Trivedi graduated from New York Medical College in 2004. Dr. Trivedi holds Florida license ME112368.

Dr. Trivedi's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Trivedi's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Trivedi is also affiliated with AdventHealth Orlando. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Trivedi to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trivedi practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Trivedi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Trivedi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Trivedi's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, lymphoma and prostate cancer among the conditions Dr. Trivedi treats.

CMS data shows 12,594 Medicare services from Dr. Trivedi across 16 procedure codes in 2024, for 538 Medicare patients. Medicare paid $109,776 for them.

CMS counts 538 Medicare patients who saw Dr. Trivedi in 2024. The largest group is 75 to 84, with 214 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trivedi's median patient age at 67, with 67% women.

In 2024, Dr. Trivedi wrote 93 Medicare Part D claims for 48 patients. 83% of them were for generic drugs. CMS names the drug for 71 of them, across 2 drugs with 11 or more claims each, at $346,646 in total drug cost. In 2021, CMS named 707 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Trivedi for performance year 2024, reported as part of a group. Dr. Trivedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trivedi as offering telehealth.

CMS Open Payments shows 181 general payments to Dr. Trivedi from 51 drug and device companies from 2016 to 2025. Gifts make up the largest share, 75% of the total. Tosoh Bioscience, Inc. paid the most, $12,360.

Dr. Trivedi graduated from New York Medical College in 2004.

Dr. Trivedi is in network with 20 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.